Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Clinical trial NCT00604058 · COMPLETED
Trial details
- NCT number
- NCT00604058
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-09-01
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.